Given the presence of common nuclear expression of LMP1 protein in our cohort (in both cancer cells and lymphocytes), future work should definitely include positive immunostains (controls) such as nasopharyngeal carcinoma and classical Hodgkin lymphoma tissues. Here, PDLIM7 is linked to Hodgkins lymphoma.